RenovoRx, Inc. (RNXT)
NASDAQ·Healthcare·Biotechnology
$1.14
+0.97%
Mkt Cap $50.55M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.14
+0.97%
Mkt Cap $50.55M
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —